secwatch.observer — SEC 8-K summary
======================================

Issuer:     Encompass Health Corp (EHC)
CIK:        0000785161
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0000785161-24-000034
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 7.01
LLM model:  deepseek-v4-flash:cloud@v2

Encompass Health reaffirms FY2024 guidance: revenue $5.25B-$5.325B, Adj. EBITDA $1.03B-$1.065B, Adj. EPS $3.86-$4.11
--------------------------------------------------------------------------------

- Reiterated full-year 2024 net operating revenue guidance of $5,250M to $5,325M.
- Reaffirmed Adjusted EBITDA guidance of $1,030M to $1,065M for 2024.
- Adjusted diluted EPS from continuing ops expected between $3.86 and $4.11.
- Fireside chat at Leerink Partners Healthcare Crossroads Conference on May 30, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/785161/000078516124000034/0000785161-24-000034-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/785161/000078516124000034/ehc-20240529.htm
  HTML page:      https://secwatch.observer/filing/0000785161-24-000034

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer